Sensodyne-maker Haleon posts tepid sales as demand for some products cools off
The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year.
Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, due to retailer destocking in the US and cooling demand for some of its medicines after a surge last year. The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first three months of 2024 would be impacted by a softer cold and flu season and a slowdown in painkiller Advil's sales in Canada, following a surge in demand last year.
Demand for medicines such as Contac and Fenbid, which benefited from pent-up demand in China last year after lockdown restrictions were lifted have also cooled, impacting Haleon's quarterly sales growth.
Revenues stood at 2.92 billion pounds ($3.64 billion) for the quarter ended March 31, slightly missing expectations of 2.93 billion pounds, according to a company-compiled consensus.
On a reported basis, revenue was down 2.2% on last year.
Shares in the FTSE 100 group fell 1.8% in early trading, to become one of the top losers on the blue-chip index. The stock has risen about 5% this year as of Tuesday's close.
Haleon, the world's biggest standalone consumer health company, comprising assets from GSK and Pfizer sells non-prescription drugs, vitamins and oral care products.
Demand for its oral health products and multivitamins held steady during the reported quarter, and the company re-affirmed its full-year outlook outlined in February.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Stocks to buy for long term: Analysts suggest buying these 5 largecap, 4 midcap scrips; check out targets
How your NPS retirement corpus and monthly pension can jump by 40% after this rule change; get details
How much investment do you need in this senior citizen scheme to get Rs 50,000 quarterly interest? Know here
Top 5 ELSS SIP Mutual Funds in 3 Years: Know what Rs 12,500 monthly SIP has turned into in all funds
01:32 PM IST